The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Open accessAbstract
Significance: We describe a blood test for detection of cell death in specific tissues based on two principles: ( i ) dying cells release fragmented DNA to the circulation, and ( ii ) each cell type has a unique DNA methylation pattern. We have identified tissue-specific DNA methylation markers and developed a method for sensitive detection of these markers in plasma or serum. We demonstrate the utility of the method for identification of pancreatic β-cell death in type 1 diabetes, oligodendrocyte death in relapsing multiple sclerosis, brain cell death in patients after traumatic or ischemic brain damage, and exocrine pancreas cell death in pancreatic cancer or pancreatitis. The approach allows minimally invasive monitoring of tissue dynamics in humans in multiple physiological and pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
International trial of the Edmonton protocol for islet transplantation
Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942 · cited 1×
“We also studied plasma samples taken from patients with longstanding T1D who had been transplanted with cadaveric allogeneic islets and treated with immune suppressants (26).”
BackgroundSelf-citationNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Sun, K., Jiang, P., Chan, K. C. A., Wong, J., Cheng, Y. K. Y., Liang, R. H. S., Chan, W.-K., Ma, E. S. K., Chan, S. L., Cheng, S. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508736112 · Cited by 774
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
DNA methylation dynamics in health and disease
Bergman, Y., & Cedar, H. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2518 · Cited by 592
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Non-invasive prenatal measurement of the fetal genome
Fan, H. C., Gu, W., Wang, J., Blumenfeld, Y. J., El-Sayed, Y. Y., & Quake, S. R. (2012) · Nature · doi:10.1038/nature11251 · Cited by 392
Universal noninvasive detection of solid organ transplant rejection
Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013924108 · Cited by 385
Role of the Blood–Brain Barrier in Multiple Sclerosis
Ortiz, G. G., Pacheco-Moisés, F. P., Macías-Islas, M. Á., Flores-Alvarado, L. J., Mireles-Ramírez, M. A., González-Renovato, E. D., Hernández-Navarro, V. E., Sánchez-López, A. L., & Alatorre-Jiménez, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.013 · Cited by 373 · cited 1×
“Both are autoimmune diseases in which oligodendrocyte and astrocyte cell death occurs and in which the blood–brain barrier is disrupted (28, 29).”
BackgroundInsulin Gene Expression Is Regulated by DNA Methylation
Kuroda, A., Rauch, T. A., Todorov, I., Ku, H. T., Al-Abdullah, I. H., Kandeel, F., Mullen, Y., Pfeifer, G. P., & Ferreri, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006953 · Cited by 311
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis
Dwivedi, D. J., Toltl, L. J., Swystun, L. L., Pogue, J., Liaw, K.-L., Weitz, J. I., Cook, D. J., Fox-Robichaud, A. E., Liaw, P. C., & the Canadian Critical Care Translational Biology Group (2012) · Critical Care · doi:10.1186/cc11466 · Cited by 306
(2014) · New England Journal of Medicine · doi:10.1056/nejmc1412266 · Cited by 291
Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains
Huynh, J. L., Garg, P., Thin, T. H., Yoo, S., Dutta, R., Trapp, B. D., Haroutunian, V., Zhu, J., Donovan, M. J., Sharp, A. J., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3588 · Cited by 279
Beck, J., Bierau, S., Balzer, S., Andag, R., Kanzow, P., Schmitz, J., Gaedcke, J., Moerer, O., Slotta, J. E., Walson, P., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210328 · Cited by 271
Randall, J., Mörtberg, E., Provuncher, G. K., Fournier, D. R., Duffy, D. C., Rubertsson, S., Blennow, K., Zetterberg, H., & Wilson, D. H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.07.027 · Cited by 230 · cited 1×
“Following cardiac arrest, patients with documented ischemic brain damage sampled at multiple time points (n = 10 patients, 60 samples) (31) all had high levels of unmethylated Brain1 in serum (Fig.”
BackgroundSelf-citationTranscriptomes of the major human pancreatic cell types
Dorrell, C., Schug, J., Lin, C. F., Canaday, P. S., Fox, A. J., Smirnova, O., Bonnah, R., Streeter, P. R., Stoeckert, C. J., Kaestner, K. H., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2283-5 · Cited by 216
Self-citationDetection of β cell death in diabetes using differentially methylated circulating DNA
Akirav, E. M., Lebastchi, J., Galvan, E. M., Henegariu, O., Akirav, M., Ablamunits, V., Lizardi, P. M., & Herold, K. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111008108 · Cited by 211
Circulating Cell-Free DNA: An Up-Coming Molecular Marker in Exercise Physiology
Breitbach, S., Tug, S., & Simon, P. (2012) · Sports Medicine · doi:10.2165/11631380-000000000-00000 · Cited by 209
Visualization of Early Engraftment in Clinical Islet Transplantation by Positron-Emission Tomography
Eich, T., Eriksson, O., & Lundgren, T. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070201 · Cited by 198
Methylation of cell-free circulating DNA in the diagnosis of cancer
Warton, K., & Samimi, G. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00013 · Cited by 185
Fackler, M. J., Lopez Bujanda, Z., Umbricht, C., Teo, W. W., Cho, S., Zhang, Z., Visvanathan, K., Jeter, S., Argani, P., Wang, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3392 · Cited by 170
β Cell death and dysfunction during type 1 diabetes development in at-risk individuals
Herold, K. C., Usmani‐Brown, S., Ghazi, T., Lebastchi, J., Beam, C. A., Bellin, M. D., Ledizet, M., Sosenko, J. M., Krischer, J. P., & Palmer, J. P. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78142 · Cited by 157
Cell-Free DNA in Serum and Plasma: Comparison of ELISA and Quantitative PCR
Holdenrieder, S., Stieber, P., Chan, L. Y. S., Geiger, S., Kremer, A. E., Nagel, D., & Lo, Y. D. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.049320 · Cited by 139
Cell‐Free DNA Levels as a Prognostic Marker in Acute Myocardial Infarction
Antonatos, D. G., Patsilinakos, S. P., SPANODIMOS, S. G., Korkonikitas, P., & Tsigas, D. L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.037 · Cited by 111
Troletti, C. D., de Goede, P., Kamermans, A., & de Vries, H. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.010 · Cited by 106
Mörtberg, E., Zetterberg, H., Nordmark, J., Blennow, K., Rosengren, L., & Rubertsson, S. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.10.011 · Cited by 99
Self-citationImmune Therapy and β-Cell Death in Type 1 Diabetes
Lebastchi, J., Deng, S., Lebastchi, A. H., Beshar, I., Gitelman, S. E., Willi, S. M., Gottlieb, P. A., Akirav, E. M., Bluestone, J. A., & Herold, K. C. (2013) · Diabetes · doi:10.2337/db12-1207 · Cited by 88
Tissue-Specific Methylation of Human Insulin Gene and PCR Assay for Monitoring Beta Cell Death
Husseiny, M. I., Kaye, A., Zebadua, E., KANDEEL, F. R., & Ferreri, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094591 · Cited by 86
Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes
Fisher, M. M., Watkins, R. A., Blum, J. S., Evans‐Molina, C., Chalasani, N., DiMeglio, L. A., Mather, K. J., Tersey, S. A., & Mirmira, R. G. (2015) · Diabetes · doi:10.2337/db15-0430 · Cited by 85
The oligodendroglia cytoskeleton in health and disease
Richter‐Landsberg, C. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000101)59:1<11::aid-jnr2>3.0.co;2-o · Cited by 78
Role of Plasma DNA as a Predictive Marker of Fatal Outcome following Severe Head Injury in Males
Yurgel, V. C., Ikuta, N., da Rocha, A. B., Lunge, V. R., Schneider, R. F., Fonseca, A. S. K., Grivicich, I., Zanoni, C., & Regner, A. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0160 · Cited by 58
Danese, E., Minicozzi, A. M., Benati, M., Montagnana, M., Paviati, E., Salvagno, G. L., Gusella, M., Pasini, F., Guidi, G. C., & Lippi, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.351 · Cited by 57
Assessment of responsiveness in acute cerebral disorders
Stålhammar, D., Starmark, J.-E., Holmgren, E., Eriksson, N., Nordström, C., Fedders, O., & Rosander, B. (1988) · Acta Neurochirurgica · doi:10.1007/bf01560558 · Cited by 57
Zhai, R., Zhao, Y., Su, L., et al. (2012) · Neoplasia · doi:10.1593/neo.111626 · Cited by 53
Comparison of the methylation patterns of the two rat insulin genes.
Cate, R. L., Chick, W. L., & Gilbert, W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32461-x · Cited by 43
Cited by
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
Moss, J., Magenheim, J., Neiman, D., Zemmour, H., Loyfer, N., Korach, A., Samet, Y., Maoz, M., Druid, H., Arner, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07466-6 · Cited by 1,012
Self-citation
Metadata
- Authors
- Lehmann-Werman, R., Neiman, D., Zemmour, H., Moss, J., Magenheim, J., Vaknin-Dembinsky, A., Rubertsson, S., Nellgård, B., Blennow, K., Zetterberg, H., Spalding, K., Haller, M. J., Wasserfall, C. H., Schatz, D. A., Greenbaum, C. J., Dorrell, C., Grompe, M., Zick, A., Hubert, A., Maoz, M., Fendrich, V., Bartsch, D. K., Golan, T., Ben Sasson, S. A., Zamir, G., Razin, A., Cedar, H., Shapiro, A. M. J., Glaser, B., Shemer, R., & Dor, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-03-14
- Volume
- 113
- Issue
- 13
- Pages
- E1826-34
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2298824325
- Cited by
- 610
- References
- 48
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.